S&P 500 7,703.24 ▲ 26.47 (+0.34%) DOW 52,307.82 â–ŧ 53.76 (-0.10%) NASDAQ 26,372.31 ▲ 202.93 (+0.78%) US Markets Open â€ĸ 10:50 AM ET

IMRN

Immuron Limited

Price Chart

No historical data available

Latest Quote

$0.92

-0.03 (-3.51%)
Current Price
Previous Close $0.95
Open $0.93
Day High $0.95
Day Low $0.92
Volume 17,312
Fetched: 2026-10-27T01:04:31
Stock Information
Note: Financial values converted from AUD to USD
Shares Outstanding 8.07M
Total Debt $133K
Cash Equivalents $6.33M
Revenue $5.41M
Net Income $-2.58M
Sector Healthcare
Industry Biotechnology
Market Cap $7.43M
EPS (TTM) $-0.34
Exchange NCM
🌐 Visit Website
Recent Price History
No history data available. Data will be fetched automatically.
About Immuron Limited

Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies for the treatment of inflammatory mediated and infectious diseases in Australia, the United States, and Canada. It operates through two segments, Research and Development; and Hyper-immune Products. The company offers Travelan, an over-the-counter medicine to reduce the risk of travelers' diarrhea and risk of minor gastrointestinal disorders, as well as a dietary supplement for digestive tract protection; ProIBS, an over the counter orally administered product containing the proprietary ingredient AVH200 for the treatment of irritable bowel syndrome; and Protectyn, an immune supplement to help maintain a healthy digestive function and liver. It also develops IMM-529, which is in Phase II clinical trial for the treatment of Clostridioides difficile infection. In addition, the company offers technology platform. The company has a collaboration with the US Naval Medical Research Command and Silver Spring, MD, USA; and a research collaboration with the Walter Reed Army Institute of Research to develop three Shigella-specific therapeutic products. The company was formerly known as Anadis Limited and changed its name to Immuron Limited in December 2008. Immuron Limited was incorporated in 1994 and is headquartered in Carlton, Australia.

📰 Latest News
No news articles available at the moment. Check back later for updates on IMRN.
Period:
Loading...
Income Statement (Annual)
Metric 2026-06-30 2025-06-30 2024-06-30 2023-06-30
Revenue
Reconciled Cost Of Revenue $1,921,235 $1,769,260 $1,098,687 $347,662
Cost Of Revenue $1,921,235 $1,769,260 $1,098,687 $347,662
Total Revenue $5,411,534 $5,112,251 $3,439,642 $1,266,104
Operating Revenue $5,411,534 $5,112,251 $3,439,642 $1,266,104
Expenses
Interest Expense $10,321 $5,125 $5,315 $6,771
Total Expenses $7,889,423 $8,870,305 $7,098,852 $3,655,974
Other Income Expense $-223,617 $8,547 $-1,432,088 $-341,419
Net Non Operating Interest Income Expense $119,774 $90,193 $224,625 $74,836
Interest Expense Non Operating $10,321 $5,125 $5,315 $6,771
Operating Expense $5,968,187 $7,101,045 $6,000,166 $3,308,311
Other Operating Expenses $-820,730 $-990,252 $-2,391,047 $-2,120,408
Selling And Marketing Expense $2,435,496 $2,422,068 $1,423,915 $650,641
General And Administrative Expense $2,983,798 $3,097,167 $3,172,044 $2,911,994
Rent Expense Supplemental - - $16,923 -
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-2,581,731 $-3,659,315 $-4,866,674 $-2,656,452
Net Interest Income $119,774 $90,193 $224,625 $74,836
Interest Income $130,095 $95,318 $229,940 $81,607
Normalized Income $-2,358,114 $-3,667,862 $-4,456,067 $-2,542,577
Net Income From Continuing And Discontinued Operation $-2,581,731 $-3,659,315 $-4,866,674 $-2,656,452
Total Operating Income As Reported $-2,701,505 $-3,749,508 $-4,069,818 $-2,503,745
Net Income Common Stockholders $-2,581,731 $-3,659,315 $-4,866,674 $-2,656,452
Net Income $-2,581,731 $-3,659,315 $-4,866,674 $-2,656,452
Net Income Including Noncontrolling Interests $-2,581,731 $-3,659,315 $-4,866,674 $-2,656,452
Net Income Continuous Operations $-2,581,731 $-3,659,315 $-4,866,674 $-2,656,452
Pretax Income $-2,581,731 $-3,659,315 $-4,866,674 $-2,656,452
Special Income Charges $-23,592 $0 $0 $-1,667
Earnings From Equity Interest $0 $0 $-1,021,481 $-227,543
Interest Income Non Operating $130,095 $95,318 $229,940 $81,607
Operating Income $-2,477,888 $-3,758,055 $-3,659,211 $-2,389,870
Depreciation Amortization Depletion Income Statement $29,690 $34,859 $32,258 $34,139
Depreciation And Amortization In Income Statement $29,690 $34,859 $32,258 $34,139
Depreciation Income Statement $29,690 $34,859 $32,258 $34,139
Gross Profit $3,490,299 $3,342,991 $2,340,955 $918,442
Per Share
Diluted EPS $-0.36 $-0.64 $-0.85 $-0.47
Basic EPS $-0.36 $-0.64 $-0.85 $-0.47
Other
Tax Effect Of Unusual Items $0 $0 $0 $0
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-2,318,103 $-3,627,878 $-4,418,494 $-2,501,666
Total Unusual Items $-223,617 $8,547 $-410,607 $-113,875
Total Unusual Items Excluding Goodwill $-223,617 $8,547 $-410,607 $-113,875
Reconciled Depreciation $29,690 $34,859 $32,258 $34,139
EBITDA (Bullshit earnings) $-2,541,720 $-3,619,331 $-4,829,101 $-2,615,542
EBIT $-2,571,409 $-3,654,190 $-4,861,359 $-2,649,681
Diluted Average Shares $5,219,124 $4,058,841 $4,002,199 $4,000,681
Basic Average Shares $5,219,124 $4,058,841 - $4,000,681
Diluted NI Availto Com Stockholders $-2,581,731 $-3,659,315 $-4,866,674 $-2,656,452
Tax Provision $0 $0 $0 $0
Write Off $23,592 $0 $0 $1,667
Gain On Sale Of Security $-200,025 $8,547 $-410,607 $-112,209
Provision For Doubtful Accounts $-16,485 $13,493 $-8,199 $13,407
Research And Development $1,356,419 $2,523,710 $3,771,195 $1,818,539
Selling General And Administration $5,419,294 $5,519,235 $4,595,959 $3,562,634
Other Gand A $998,799 $1,017,165 $1,166,506 $1,033,114
Insurance And Claims $228,510 $248,104 $225,676 $304,966
Salaries And Wages $1,756,489 $1,831,898 $1,779,863 $1,573,913
Rent And Landing Fees - - $16,923 -
Other Special Charges - - - -
Other Taxes - - - -
Fetched: 2026-10-27
Balance Sheet (Annual)
Metric 2026-06-30 2025-06-30 2024-06-30 2023-06-30
Assets
Net Tangible Assets $7,832,908 $5,660,906 $8,916,405 $13,762,338
Total Assets $9,226,672 $7,106,666 $10,909,197 $15,425,973
Total Non Current Assets $135,205 $80,410 $577,825 $1,107,650
Current Assets $9,091,467 $7,026,257 $10,331,372 $14,318,323
Prepaid Assets $181,140 $2,440,773 $60,894 $110,952
Inventory $1,595,235 $1,243,414 $1,111,694 $589,286
Receivables $988,577 $1,350,914 $973,462 $292,844
Other Receivables $548,838 $795,708 $558,699 $279,494
Accounts Receivable $439,740 $555,206 $414,763 $13,350
Allowance For Doubtful Accounts Receivable $-8,396 $-24,881 $-11,388 $-19,587
Gross Accounts Receivable $448,136 $580,088 $426,151 $32,937
Cash Cash Equivalents And Short Term Investments $6,326,515 $1,985,777 $8,178,276 $13,325,241
Cash And Cash Equivalents $6,326,515 $1,985,777 $8,178,276 $12,038,560
Cash Financial $6,326,515 $1,985,777 $8,178,276 $12,038,560
Other Non Current Assets - $467 $469,542 $855,652
Other Current Assets - $5,378 $7,046 -
Debt
Total Debt - $50,410 $93,266 $132,659
Long Term Debt And Capital Lease Obligation - $50,410 $93,266 $105,462
Current Debt And Capital Lease Obligation - - $28,452 $27,197
Liabilities
Total Liabilities Net Minority Interest $1,393,764 $1,445,760 $1,992,792 $1,663,635
Total Non Current Liabilities Net Minority Interest $141,116 $66,351 $99,303 $106,782
Other Non Current Liabilities $111,503 $50,410 - -
Current Liabilities $1,252,648 $1,379,409 $1,893,489 $1,556,854
Other Current Liabilities $21,472 $31,761 $28,452 -
Payables And Accrued Expenses $943,935 $1,072,987 $1,498,423 $836,796
Payables $638,251 $727,222 $484,356 $560,364
Other Payable $16,752 $20,989 $29,150 $5,489
Accounts Payable $621,499 $706,233 $455,206 $554,875
Current Deferred Liabilities - - $0 $489,824
Equity
Common Stock Equity $7,832,908 $5,660,906 $8,916,405 $13,762,338
Total Equity Gross Minority Interest $7,832,908 $5,660,906 $8,916,405 $13,762,338
Stockholders Equity $7,832,908 $5,660,906 $8,916,405 $13,762,338
Gains Losses Not Affecting Retained Earnings $336,392 $1,150,206 $2,226,601 $2,270,218
Retained Earnings $-59,611,445 $-57,838,645 $-55,400,867 $-50,551,001
Long Term Equity Investment - - $0 $111,594
Other
Ordinary Shares Number $226,496,480 $164,135,691 $159,953,941 $159,813,629
Share Issued $226,496,480 $164,135,691 $159,953,941 $159,813,629
Tangible Book Value $7,832,908 $5,660,906 $8,916,405 $13,762,338
Invested Capital $7,832,908 $5,660,906 $8,916,405 $13,762,338
Working Capital $7,838,819 $5,646,847 $8,437,883 $12,761,469
Total Capitalization $7,832,908 $5,660,906 $8,916,405 $13,762,338
Capital Stock $67,107,962 $62,349,345 $62,090,672 $62,043,120
Common Stock $67,107,962 $62,349,345 $62,090,672 $62,043,120
Employee Benefits $29,613 $15,941 $6,037 $1,320
Pensionand Other Post Retirement Benefit Plans Current $287,241 $274,662 $366,614 $203,036
Current Accrued Expenses $305,684 $345,765 $1,014,067 $276,432
Net PPE $135,205 $79,942 $108,283 $140,405
Gross PPE $135,205 $79,942 $456,842 $456,705
Other Properties $135,205 $79,942 - $170,725
Finished Goods $387,705 $799,811 $427,964 $276,681
Work In Process $910,514 $303,810 $479,760 $312,126
Raw Materials $297,016 $139,769 $98,039 $0
Capital Lease Obligations - $50,410 $93,266 $132,659
Long Term Capital Lease Obligation - $50,410 $93,266 $105,462
Other Inventories - $25 $105,930 $478
Treasury Shares Number - - $0 -
Current Deferred Revenue - - $0 $489,824
Current Capital Lease Obligation - - $28,452 $27,197
Investments And Advances - - $0 $111,594
Accumulated Depreciation - - $-348,559 $-316,301
Leases - - $170,725 $170,725
Machinery Furniture Equipment - - $286,118 $285,981
Properties - - $0 $0
Other Short Term Investments - - $0 $1,286,680
Current Provisions - - - -
Fetched: 2026-10-27
Cash Flow Statement (Annual)
Metric 2026-06-30 2025-06-30 2024-06-30 2023-06-30
Free Cash Flow
Free Cash Flow $-2,290,215 $-4,305,422 $-4,125,392 $-1,826,108
Operating Activities
Cash Flowsfromusedin Operating Activities Direct $-2,286,881 $-4,305,422 $-4,125,255 $-1,820,678
Classesof Cash Receiptsfrom Operating Activities $6,966,445 $6,058,466 $4,932,380 $3,680,972
Other Cash Receiptsfrom Operating Activities - - - -
Investing Activities
Capital Expenditure $-3,334 - $-137 $-5,429
Investing Cash Flow $2,273,504 $-2,034,806 $229,803 $-1,838,978
Cash Flow From Continuing Investing Activities $2,273,504 $-2,034,806 $229,803 $-1,838,978
Financing Activities
Repurchase Of Capital Stock $-85,434 $0 $0 -
Issuance Of Capital Stock $5,015,222 $278,397 $16,837 $0
Financing Cash Flow $4,542,697 $140,134 $582 $-31,336
Cash Flow From Continuing Financing Activities $4,542,697 $140,134 $582 $-31,336
Net Other Financing Charges $-345,956 $-87,073 - -
Cash Dividends Paid $0 $0 $0 $0
Net Common Stock Issuance $4,929,789 $278,397 $16,837 $0
Common Stock Issuance $5,015,222 $278,397 $16,837 $0
Other
Repayment Of Debt $-30,815 $-46,065 $-10,941 $-24,565
End Cash Position $6,326,515 $1,985,777 $8,178,276 $12,038,560
Beginning Cash Position $1,985,777 $8,178,276 $12,038,560 $15,511,630
Effect Of Exchange Rate Changes $-188,581 $7,594 $34,587 $217,923
Changes In Cash $4,529,320 $-6,200,094 $-3,894,871 $-3,690,993
Interest Paid Cff $-10,321 $-5,125 $-5,315 $-6,771
Common Stock Payments $-85,434 $0 $0 -
Net Issuance Payments Of Debt $-30,815 $-46,065 $-10,941 $-24,565
Net Long Term Debt Issuance $-30,815 $-46,065 $-10,941 $-24,565
Long Term Debt Payments $-30,815 $-46,065 $-10,941 $-24,565
Interest Received Cfi $146,714 $95,318 $229,940 $81,607
Net Investment Purchase And Sale $2,130,123 $-2,130,123 $0 $0
Sale Of Investment $2,130,123 - - -
Net PPE Purchase And Sale $-3,334 $0 $-137 $-5,429
Purchase Of PPE $-3,334 $0 $-137 $-5,429
Taxes Refund Paid Direct $779,089 $539,100 $277,116 $176,783
Classesof Cash Payments $-9,253,325 $-10,363,889 $-9,057,635 $-5,501,650
Paymentsto Suppliersfor Goodsand Services $-9,253,325 $-10,363,889 $-9,057,635 $-5,501,650
Receiptsfrom Government Grants $238,403 $192,737 $1,333,845 $2,162,328
Receiptsfrom Customers $5,948,953 $5,326,629 $3,321,419 $1,341,861
Purchase Of Investment - $-2,130,123 $0 $0
Net Business Purchase And Sale - $0 $0 $-1,915,156
Purchase Of Business - $0 $0 $-1,915,156
Issuance Of Debt - - - $0
Long Term Debt Issuance - - - $0
Fetched: 2026-10-27